VRCA (STOCKS)
Verrica Pharmaceuticals Inc. Common Stock
$5.620000
+0.510000 (+9.98%)
Prev close: $5.110000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jayson M. Rieger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $96.46M
- Employees
- 71
- P/E (TTM)
- -3.50
- P/B (TTM)
- 3.55
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $35.58M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $47.76M |
| Nonoperating Income/Loss | -$5.70M |
| Operating Expenses | $47.76M |
| Selling, General, and Administrative Expenses | $35.22M |
| Research and Development | $8.86M |
| Other Operating Expenses | $3.69M |
| Operating Income/Loss | -$12.19M |
| Income/Loss From Continuing Operations After Tax | -$17.89M |
| Income/Loss From Continuing Operations Before Tax | $35.58M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$17.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$17.89M |
| Net Income/Loss Available To Common Stockholders, Basic | -$17.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.68 |
| Diluted Earnings Per Share | -$1.68 |
| Basic Average Shares | 10,652,367 |
| Diluted Average Shares | 10,652,367 |
| Assets | $47.13M |
| Current Assets | $42.54M |
| Inventory | $2.24M |
| Other Current Assets | $40.30M |
| Noncurrent Assets | $4.59M |
| Fixed Assets | $209.00K |
| Other Non-current Assets | $4.38M |
| Liabilities | $22.39M |
| Current Liabilities | $16.44M |
| Accounts Payable | $2.07M |
| Wages | $1.76M |
| Other Current Liabilities | $12.60M |
| Noncurrent Liabilities | $5.95M |
| Long-term Debt | $0.00 |
| Equity | $24.74M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $24.74M |
| Liabilities And Equity | $47.13M |
| Net Cash Flow From Operating Activities | -$17.63M |
| Net Cash Flow From Operating Activities, Continuing | -$17.63M |
| Net Cash Flow From Investing Activities | $16.18M |
| Net Cash Flow From Investing Activities, Continuing | $16.18M |
| Net Cash Flow From Financing Activities | $1.45M |
| Net Cash Flow From Financing Activities, Continuing | $1.45M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$17.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$17.89M |
| Other Comprehensive Income/Loss | $0.00 |